Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07210710
Recruiting
CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD
Not applicable · United States · 1 site
Registry update: 9 Oct 2026
NCT07244952
Recruiting
Effects of Vojta Therapy on Posture and Trunk Control
Not applicable · Pakistan · 1 site
Registry update: 28 Nov 2025
NCT06828471
Recruiting
Social Cognition Training in Individuals With Huntington's Disease
Not applicable · United States · 1 site
Registry update: 10 Dec 2025
NCT07264452
Recruiting
Comparison of the Efficacy of Accelerated Intermittent Theta Burst Stimulation and Accelerated Continuous Theta Burst Stimulation in Patients With Treatment-Resistant Depression
Not applicable · 1 site
Registry update: 4 Dec 2025
NCT07090005
Recruiting
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Not applicable · Italy, United States · 5 sites
Registry update: 1 Oct 2026
NCT06904170
Recruiting
Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma
Phase 2/3 · France · 13 sites
Registry update: 3 Feb 2026
Conflicting statuses (not updated in the registry for 9 months)
NCT07259226
Recruiting
Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers
Phase 2 · France · 1 site
Registry update: 2 Dec 2025
NCT07280143
Recruiting
The Development of MASLD Among Survivors of Breast or Colorectal Cancer
Not applicable · Switzerland · 1 site
Registry update: 12 Dec 2025
NCT07254065
Recruiting
Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Pilot RCT
Not applicable · United States · 1 site
Registry update: 28 Nov 2025
NCT06554223
Recruiting
The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care
Not applicable · South Africa · 1 site
Registry update: 24 Nov 2025
2025-523061-22-00
Recruiting
A Phase II, Open-Label, Single-Center, Single-Arm Pilot Study to Evaluate the Safety, Tolerability and Efficacy of Blinatumomab for Treatment of Patients with Autoimmune B-Cell driven Diseases including Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc) and Granulomatous Polyangiitis (GPA), BlinA-B trial
Phase 2 · Germany · 1 site
Registry update: 2 Oct 2026
NCT07564570
Recruiting
Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma
Not applicable · Germany · 1 site
Registry update: 4 May 2026
2025-520555-89-00
Recruiting
Phase 3 Study of Xaluritamig Plus Abiraterone vs Investigator's Choice in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Phase 3 · Austria, Belgium, Germany, Spain, France, Greece, Italy, Netherlands, Portugal · 73 sites
Registry update: 17 Sept 2026
NCT07269626
Recruiting
PULSAR in Systemic Therapy for Pancreatic Cancer
Phase 2 · South Korea · 1 site
Registry update: 8 Dec 2025
NCT07092566
Recruiting
R.E.C.K vs Exparel in Robotic Nephrectomy
Phase 3 · United States · 1 site
Registry update: 13 Jul 2026
NCT07219420
Recruiting
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Phase 3 · Canada, China, Czechia, Germany, Denmark, Spain, France, United Kingdom, Hungary, Italy, South Korea, Poland, United States · 91 sites
Registry update: 27 Aug 2026
NCT07031336
Recruiting
Photon-counting CT in Chest Imaging
Not applicable · United States · 1 site
Registry update: 26 Aug 2026
NCT07313241
Recruiting
Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)
Phase 2 · United States · 1 site
Registry update: 30 Jun 2026
NCT07116434
Recruiting
Discovery Diabetes
Not applicable · United States · 1 site
Registry update: 23 Dec 2025
NCT07201376
Recruiting
Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically
Not applicable · United States · 1 site
Registry update: 6 Feb 2026

Ordered by registry start date. Freshness and sponsorship never change the order.